Key result
Lifelong risk tracking with female-specific modifiers outperforms standard 10-year CVD estimates in women.
Why the study?
Cardiovascular disease is the leading cause of death in women, yet risk is frequently underestimated during early and middle adulthood, and a life-course perspective may identify periods when female-specific factors reveal or accelerate cardiovascular vulnerability.
Answers are grounded in this paper and cite their sources.
This narrative review highlights the need to shift cardiovascular prevention in women from isolated 10-year risk estimates to longitudinal assessments that integrate reproductive history, female-specific risk modifiers, and targeted imaging across key life transitions.
Cardiovascular disease remains the leading cause of death in women, yet risk is frequently underestimated, particularly during early and middle adulthood. A life-course perspective may identify periods in which female-specific factors reveal or accelerate cardiovascular vulnerability. This narrative review examines cardiovascular risk across adolescence, reproductive life, pregnancy, the postpartum period, menopause, and older age. Relevant literature was identified through a targeted PubMed search, supplemented by major international guidelines and reference screening. The review addresses reproductive and pregnancy-related risk factors, female-predominant conditions, limitations of current prediction models, and the potential contribution of biomarkers and imaging, including coronary artery calcium and breast arterial calcification. Cardiovascular prevention in women should move beyond isolated 10-year risk estimates towards longitudinal assessment that incorporates reproductive history and female-specific risk modifiers. Pregnancy and the postpartum period are underused opportunities for early prevention, whereas selected imaging tools may improve risk classification when conventional scores are uncertain. Future progress will require structured follow-up pathways, multidisciplinary care, systematic capture of female-specific risk factors, and prediction models validated in diverse female populations. We distinguish epidemiological associations from independently validated risk prediction and from interventions with demonstrated clinical benefit, and propose a staged, guideline-anchored pathway for reassessment at key life transitions.
No takes yet. Share an insight, caveat, or question.
Giamundo et al. (2026) conducted a review in Cardiovascular disease risk across the female life course. Longitudinal cardiovascular risk assessment incorporating reproductive history, female-specific risk modifiers, biomarkers, and imaging vs. Isolated 10-year risk estimates was evaluated on Cardiovascular risk identification, classification, and prevention. Longitudinal cardiovascular risk assessment incorporating reproductive history, female-specific risk modifiers, and selected imaging should replace isolated 10-year risk estimates in women.
Synapse has enriched 10 related papers. Consider them for comparative context: